The Development of Synthetic Vaccines
- 8 December 1981
- journal article
- research article
- Published by Taylor & Francis in Hospital Practice
- Vol. 16 (12), 55-62
- https://doi.org/10.1080/21548331.1981.11946879
Abstract
Technology is now available for synthesis of vaccines derived from short amino acid sequences on the surface of a virus or other pathogen. Such small peptide sequences are capable of “recognizing” the entire pathogen and of stimulating effective antibody production. These synthetic vaccines are potentially “medically ideal” agents, whose clinical applicability is now being explored.Keywords
This publication has 4 references indexed in Scilit:
- Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.Proceedings of the National Academy of Sciences, 1981
- Antibodies to chemically synthesized peptides predicted from DNA sequences as probes of gene expressionCell, 1981
- Chemically Defined Antiviral VaccinesAnnual Review of Microbiology, 1980
- Hepatitis B virus genes and their expression in E. coliNature, 1979